Moreover, hippocampal inflammation and hyperactivation of glial cells in the AD mouse model were significantly improved after lateral ventricle administration of BMSC-exos, and the protein expression levels of BACE, Aβ1-42 and p-Tau were significantly reduced, while the expression level of BDNF was significantly increased. The gene discussed is MAPT; the disease is Alzheimer disease.